ArticleCancers2026

A TP53-Pathway-Based Prognostic Signature for Radiotherapy and Functional Validation of TP53I3 in Non-Small-Cell Lung Cancer.

Xiang Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.